Anebulo Pharmaceuticals, Inc. (ANEB)
Nasdaq: ANEB · CIK 0001815974 · United States
Every official Anebulo Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ANEB filings
Anebulo Pharmaceuticals, Inc. documents
- Anebulo Pharmaceuticals, Inc. 10-K 2026ANEB 10-K 2026: annual report for fiscal 2026
- Anebulo Pharmaceuticals, Inc. 10-K 2025ANEB 10-K 2025: annual report for fiscal 2025
- Anebulo Pharmaceuticals, Inc. 10-K 2024ANEB 10-K 2024: annual report for fiscal 2024
- Anebulo Pharmaceuticals, Inc. 10-K 2023ANEB 10-K 2023: annual report for fiscal 2023
- Anebulo Pharmaceuticals, Inc. 10-K 2022ANEB 10-K 2022: annual report for fiscal 2022
- Anebulo Pharmaceuticals, Inc. 10-Q 2026ANEB 10-Q 2026: quarterly report for fiscal 2026
- Anebulo Pharmaceuticals, Inc. 10-Q 2025ANEB 10-Q 2025: quarterly report for fiscal 2025
- Anebulo Pharmaceuticals, Inc. 10-Q 2024ANEB 10-Q 2024: quarterly report for fiscal 2024
- Anebulo Pharmaceuticals, Inc. 10-Q 2023ANEB 10-Q 2023: quarterly report for fiscal 2023
- Anebulo Pharmaceuticals, Inc. 10-Q 2022ANEB 10-Q 2022: quarterly report for fiscal 2022
- Anebulo Pharmaceuticals, Inc. 8-K 2026ANEB 8-K 2026: current report for fiscal 2026
- Anebulo Pharmaceuticals, Inc. 8-K 2025ANEB 8-K 2025: current report for fiscal 2025
- Anebulo Pharmaceuticals, Inc. 8-K 2024ANEB 8-K 2024: current report for fiscal 2024
- Anebulo Pharmaceuticals, Inc. 8-K 2023ANEB 8-K 2023: current report for fiscal 2023
- Anebulo Pharmaceuticals, Inc. 8-K 2022ANEB 8-K 2022: current report for fiscal 2022
- Anebulo Pharmaceuticals, Inc. DEF 14A 2026ANEB DEF 14A 2026: proxy statement for fiscal 2026
- Anebulo Pharmaceuticals, Inc. DEF 14A 2025ANEB DEF 14A 2025: proxy statement for fiscal 2025
- Anebulo Pharmaceuticals, Inc. DEF 14A 2024ANEB DEF 14A 2024: proxy statement for fiscal 2024
- Anebulo Pharmaceuticals, Inc. DEF 14A 2023ANEB DEF 14A 2023: proxy statement for fiscal 2023
- Anebulo Pharmaceuticals, Inc. DEF 14A 2022ANEB DEF 14A 2022: proxy statement for fiscal 2022
- Anebulo Pharmaceuticals, Inc. Form 4 2026ANEB Form 4 2026: insider trading filing for fiscal 2026
- Anebulo Pharmaceuticals, Inc. Form 4 2025ANEB Form 4 2025: insider trading filing for fiscal 2025
- Anebulo Pharmaceuticals, Inc. Form 4 2024ANEB Form 4 2024: insider trading filing for fiscal 2024
- Anebulo Pharmaceuticals, Inc. Form 4 2023ANEB Form 4 2023: insider trading filing for fiscal 2023
- Anebulo Pharmaceuticals, Inc. Form 4 2022ANEB Form 4 2022: insider trading filing for fiscal 2022
- Anebulo Pharmaceuticals, Inc. S-1 2026ANEB S-1 2026: registration statement for fiscal 2026
- Anebulo Pharmaceuticals, Inc. S-1 2025ANEB S-1 2025: registration statement for fiscal 2025
- Anebulo Pharmaceuticals, Inc. S-1 2024ANEB S-1 2024: registration statement for fiscal 2024
- Anebulo Pharmaceuticals, Inc. S-1 2023ANEB S-1 2023: registration statement for fiscal 2023
- Anebulo Pharmaceuticals, Inc. S-1 2022ANEB S-1 2022: registration statement for fiscal 2022
- Anebulo Pharmaceuticals, Inc. 13F 2026ANEB 13F 2026: institutional holdings for fiscal 2026
- Anebulo Pharmaceuticals, Inc. 13F 2025ANEB 13F 2025: institutional holdings for fiscal 2025
- Anebulo Pharmaceuticals, Inc. 13F 2024ANEB 13F 2024: institutional holdings for fiscal 2024
- Anebulo Pharmaceuticals, Inc. 13F 2023ANEB 13F 2023: institutional holdings for fiscal 2023
- Anebulo Pharmaceuticals, Inc. 13F 2022ANEB 13F 2022: institutional holdings for fiscal 2022
More companies